New York Regional Center for Diabetes Translation Research

纽约糖尿病翻译研究区域中心

• 批准号: 10016091
• 负责人: JEFFREY S GONZALEZ
• 金额: $ 57.32万
• 依托单位: ALBERT EINSTEIN COLLEGE OF MEDICINE
• 依托单位国家: 美国
• 财政年份: 2016
• 资助国家: 美国
• 起止时间: 2016-09-20 至 2021-07-31
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/10016091
• 关键词: Academic Medical Centers; Area; Basic Science; Clinical; Clinical and Translational Science Awards; Collaborations; Communities; Core Facility; Coupled; Data Sources; Diabetes Mellitus; Endocrinology; Faculty; Feasibility Studies; Fees; Fostering; Foundations; Funding; Gap Junctions; Goals; Growth; Growth and Development function; Health; Health Promotion; Health system; Healthcare; Hispanic Community Health Study/Study of Latinos; Home environment; Institution; Interdisciplinary Study; Intervention; Investigation; Latino; Life Cycle Stages; Medicine; Methodology; National Institute of Diabetes and Digestive and Kidney Diseases; Nature; New York; New York City; Obesity; Outcome; Pilot Projects; Population; Positioning Attribute; Prevention; Problem Solving; Process; Productivity; Public Health; Recording of previous events; Research; Research Personnel; Research Training; Resources; Services; Structure; Technology; Translational Research; Translations; United States National Institutes of Health; Vision; analytical method; base; bench to bedside; biopsychosocial; career; college; community center; diabetes control; diabetes risk; health care disparity; health equity; implementation science; improved; innovation; large datasets; medical schools; metropolitan; outreach; patient oriented; podcast; population health; programs; public health relevance; symposium; underserved minority; urban area; virtual

CENTER OVERVIEW The New York Regional Center for Diabetes Translation Research (NY Regional CDTR) is proposed as a new entity to maximize the assets devoted to diabetes and obesity research in the high-need, culturally diverse New York area. This Center will greatly expand the resources to support type II translational research and foster further collaborative efforts to drive cutting-edge translational research throughout the greater New York City area, with the Albert Einstein College of Medicine serving as a central collaborating hub for these efforts. The intrinsic strength of our multidisciplinary research base and diversity of patient- and community-centered activities provide an integrated platform upon which the CDTR proposal has developed and will continue to expand strong linkages among our other NIH-funded Centers. In the NY Regional CDTR, our goals will be to improve and expand delivery of existing services, develop innovative services, increase the breadth and collaborative nature of diabetes-related research investigation and stakeholder engagement. Our fruitful outreach efforts, strong interactions with the Icahn School of Medicine at Mount Sinai, Institutional support, and outstanding Institutional Core facilities coupled with a robust and highly interactive translational research base ideally positioned us to create this new application for a NY Regional CDTR. Our CDTR is structured to provide services through four cutting-edge Cores that will operate seamlessly within and between institutions without any of the typical administrative red tape or additional fee structures that can hamper these types of efforts. Guided by our Center themes that focus on promoting health equity and a biopsychosocial approach to type II translational research, we will implement our strategic vision as described in this section. To meet these challenges, the NY Regional CDTR will focus efforts on the following Specific Aims: 1) To foster the growth and development of an existing outstanding scientific base devoted to type II translational research related to the prevention and control of diabetes and its complications by supporting and administering four translational research cores, including a National Resource Core: a) Translational Intervention Methodology Core, b) Life Course Methodology Core, c) Population Health and Health Systems Core, d) Latino Network for Diabetes Translation Research: A National Resource Core. 2) To promote a Pilot & Feasibility Study Program that supports initiation of research programs in diabetes- related type II translational research and enhances the careers of new investigators. 3) To support and organize the Enrichment Program of the NY Regional CDTR by maintaining accessible outstanding, live and virtual, interactive, external and internal seminars, podcasts, faculty/trainee conferences. 4) To provide an Administrative Core as the principal means of planning, implementing and evaluating the programs in research, training, resources and enrichment activities. 5) To expand and integrate the scientific efforts of the NY Regional CDTR with our innovative Latino Network for Diabetes Translation Research national resource core that engages investigators leading the NIH-funded Hispanic Community Health Study/Study of Latinos and others funded for Latino diabetes research.

中心概况 糖尿病转化研究纽约区域中心（NY Regional CDTR）被提议作为 一个新的实体，以最大限度地提高资产致力于糖尿病和肥胖症的研究，在高需求，文化多样性 纽约地区。该中心将大大扩大资源，以支持II型转化研究， 促进进一步的合作努力，以推动整个大纽约的尖端翻译研究 城市地区，阿尔伯特·爱因斯坦医学院作为这些努力的中心合作中心。 我们的多学科研究基地的内在力量和以患者和社区为中心的多样性 这些活动提供了一个综合平台，CDTR提案就是在这个平台上发展起来的，并将继续发展下去， 扩大我们其他NIH资助中心之间的紧密联系。在纽约地区CDTR，我们的目标是 改善和扩大现有服务的提供，发展创新服务，扩大广度， 糖尿病相关研究调查的协作性质和利益相关者的参与。我们的成果 外展工作，与西奈山伊坎医学院的强有力互动，机构支持，以及 杰出的机构核心设施，加上强大的和高度互动的翻译研究基地 使我们能够为纽约区域CDTR创建这一新应用程序。我们的CDTR结构可提供 通过四个尖端核心提供服务，这些核心将在机构内部和机构之间无缝运行， 任何典型的行政繁文缛节或额外的费用结构，可能会阻碍这些类型的努力。 在我们中心主题的指导下，重点是促进健康公平和生物心理社会方法， 第二类转化研究，我们将实施我们的战略愿景，如本节所述。 为了应对这些挑战，纽约区域CDTR将集中努力实现以下具体目标： 1)促进专门研究第二类药物的现有杰出科学基地的成长和发展， 与糖尿病及其并发症的预防和控制有关的转化研究， 管理四个翻译研究核心，包括一个国家资源核心： 干预方法核心，B）生命历程方法核心，c）人口健康与保健 系统核心，d）拉丁裔糖尿病翻译研究网络：国家资源核心。 2)促进试点和可行性研究计划，支持糖尿病研究计划的启动- 相关的II型转化研究，并提高新的研究人员的职业生涯。3)支持和 组织纽约地区CDTR的丰富计划，保持可访问的优秀，实时和 虚拟、互动、外部和内部研讨会、播客、教师/学员会议。4)提供一种 行政核心作为规划、实施和评估方案的主要手段， 研究、培训、资源和丰富活动。5)扩大和整合联合国系统的科学努力， 纽约地区CDTR与我们的创新拉丁美洲网络糖尿病翻译研究国家资源 核心是让研究人员领导NIH资助的西班牙裔社区健康研究/拉丁裔研究 其他人则资助拉丁裔糖尿病研究。